Biểu đồ giá cổ phiếu NRSN
NRSN Dự đoán giá cổ phiếu
Neurosense Therapeutics Ltd
$0
0%
$0
Tính đến ngày hôm nay:Jun 29, 15:21:05 GMT-4
Quay lại
Neurosense Therapeutics Ltd (NRSN) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
--
Giá mở cửa
--
Phạm vi ngày
-
Phạm vi 52 tuần
-
Khối lượng
--
Khối lượng trung bình
157.7K
Tỷ suất cổ tức
--
EPS (TTM)
-0.62
Vốn hóa thị trường
--
NRSN là gì?
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The firm's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
